Back to Results
First PageMeta Content
Carbapenem antibiotics / Beta-lactam antibiotics / Enantiopure drugs / Beta-lactamase / Microbiology / Imipenem / Community-acquired pneumonia / Nosocomial infection / Medicine / Infectious diseases / Health


Rationale for the EUCAST clinical breakpoints
Add to Reading List

Document Date: 2009-12-12 17:13:00

Open Document

File Size: 343,38 KB

Share Result on Facebook

Company

Bacteroides / Merck & Co. / /

IndustryTerm

fragilis / /

MedicalCondition

Pseudomonas / pneumonia / Providencia stuartii Pseudomonas / nosocomial pneumonia / aeruginosa Pseudomonas / Gram-negative infections / Enterobacteriaceae Pseudomonas / skin infections / severe infections / septicaemia / post-operative sepsis / soft tissue infections / animal model infections / /

Organization

ND ND / /

Person

DIN NWGA SRGA / DIN NWGA SRGA CLSI / /

Position

General / /

Product

penicillin / /

Technology

Pharmacokinetics / Pharmacodynamics / /

URL

http /

SocialTag